Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes
Introduction
Non-alcoholic fatty liver disease (NAFLD), one of the most common causes of chronic liver disease in the world [1], [2], results from excessive fat accumulation, not alcohol abuse, in the liver. It is associated with nonalcoholic steatohepatitis (NASH), which is characterized by steatosis, various degrees of inflammation, and fibrosis/cirrhosis. The pathogenesis and progression of NASH can be explained by the “two-hit hypothesis” [3], [4]. According to this theory, the first hit involves the accumulation of fat in hepatocytes owing to insulin resistance. The progression of hepatic steatosis to NASH is then induced by hepatic injury attributable to oxidative stress, reactive oxygen species, lipid peroxidation, and cytokines (the second hit). These factors result in hepatocellular injury and subsequent progression toward hepatic fibrosis.
Olive oil, an important component of the Mediterranean diet, is known to be effective in the prevention of cancer, cardiovascular disease and chronic degenerative disease [5], [6], [7]. Oleuropein, the most abundant compound in olive leaves, can produce other bioactive substances, including oleanolic acid and hydroxytyrosol, by hydrolysis. Corona et al [8] first demonstrated that although oleuropein is not absorbed in the small intestine but it is rapidly degraded by the colonic microflora to yield hydroxytyrosol, which may then be absorbed. However, how oleuropein reaches the liver and whether it is effective in vivo are unclear. Recently, Poudyal et al [9] reported that an olive leaf extract reduced the weight of the liver in a high-fat-fed rat model by reducing portal collagen deposition and fat deposition in the liver.
Previous research has demonstrated the preventive effect of oleuropein against steatohepatitis induced by a high-fat diet in rodents [10]. However, the mechanism underlying its hepatic lipid-lowering effect remains unclear. Based on previous results, we hypothesized that oleuropein prevents hepatic steatosis induced by free fatty acids (FFA). To test our hypothesis, we established FFA-induced steatotic cells using the human hepatoma-derived cell line HepG2 and normal mouse hepatocyte FL83B cells. HepG2 cells were selected because the cell line has been successfully used to establish a stable in vitro steatosis model in previous studies. However, the epigenetic and genetic alterations in this cell line confer many properties that are distinct from those of normal hepatocytes, including differences in metabolism regulation [11], [12]. Accordingly, we employed normal mouse hepatocytes to further test our hypothesis in this study. Based on our hypothesis, this investigation determined the anti-steatotic effects, oleuropein on steatotic hepatocytes at the cellular and molecular level.
Section snippets
Cell culture and FFA treatment
HepG2 and FL83B cells in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum, 100 μg/mL penicillin, and 0.25 μg/mL streptomycin were maintained at 37°C in a humidified incubator with 5% CO2. Fatty acid-free bovine serum albumin (BSA, 1%; Sigma-Aldrich, St. Louis, MO, USA) was used as a vehicle for FFA treatment. After reaching 70% confluence, cultured cells were serum-starved and exposed to0.5 mmol/L FFAs (oleic acid:palmitic acid, 2:1)
FFA treatment induces cellular steatosis
Recently, we reported that oleuropein displayed a protective effect against high-fat diet–induced hepatic steatosis in a mouse model [8]. In the present study, we examined whether oleuropein could prevent FFA-induced steatosis in an in vitro model.
To determine the optimal concentration of FFA to induce steatosis, HepG2 or FL83B cells were cultured with FFAs (oleate:palmitate, 2:1) at a concentration of 0.5, 1, 1.5, or 2 mmol/L for 24 hours. Treatment with 0.5 or 1 mmol/L FFAs (oleate:palmitate,
Discussion
NAFLD, one of the most common hepatic disorders in developed countries, encompasses a spectrum of liver diseases, ranging from simple steatosis to steatosis combined with various degrees of necroinflammation and fibrosis. Patients with NAFLD display increased lipolysis and increased delivery of FFAs to the liver. Higher concentrations of FFAs are associated with more severe liver disease[18]. Generally, animal models have been used to study NAFLD, but these models are difficult to prepare, and
Acknowledgment
This study was supported by a grant from the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A090282) and the National Research Foundation of Korea grant funded by the Korean government (MEST) (No. 2011-0014620).
References (34)
NASH-related liver failure: one hit too many?
Am J Gastroenterol
(2002)- et al.
Steatohepatitis: a tale of two “hits”?
Gastroenterology
(1998) - et al.
The antioxidant/anticancer potential of phenolic compounds isolated from olive oil
Eur J Cancer
(2000) - et al.
Olive-oil consumption and health: the possible role of antioxidants
Lancet Oncol
(2000) - et al.
Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats
J Nutr
(2010) - et al.
Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice
J Hepatol
(2011) - et al.
A human hepatocellular in vitro model to investigate steatosis
Chem Biol Interact
(2007) - et al.
Flow cytometry of apoptotic cell death
J Immunol Methods
(2000) - et al.
Spectrofluorometric studies of the lipid probe, nile red
J Lipid Res
(1985) - et al.
Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity
Cell
(2003)
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Gastroenterology
Different role of saturated and unsaturated fatty acids in beta-cell apoptosis
Biochem Biophys Res Commun
Molecular cloning and characterization of genes encoding two microsomal oleatedesaturases (FAD2) from olive
Phytochemistry
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis
J Biol Chem
Signal transduction by the c-Jun N-terminal kinase (JNK)—from inflammation to development
Curr Opin Cell Biol
Mitogen-activated protein kinase pathways
Curr Opin Cell Biol
The JNK signal transduction pathway
Curr Opin Cell Biol
Cited by (45)
Olea europaea L-derived secoiridoids: Beneficial health effects and potential therapeutic approaches
2024, Pharmacology and TherapeuticsAdipose and non-adipose perspectives of plant derived natural compounds for mitigation of obesity
2021, Journal of EthnopharmacologyOleic acid and olive oil polyphenols downregulate fatty acid and cholesterol synthesis in brain and liver cells
2020, Olives and Olive Oil in Health and Disease PreventionThe olive-tree leaves as a source of high-added value molecules: Oleuropein
2020, Studies in Natural Products ChemistryThe olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides
2018, Journal of Nutritional BiochemistryOleuropein as an Antioxidant and Liver Protect
2018, The Liver: Oxidative Stress and Dietary Antioxidants